Brief: Oncosil Medical Appoints Shelley Steyn As CFO
18/03/2025 24:22
March 18 (Reuters) - Oncosil Medical Ltd OSL.AX: APPOINTS SHELLEY STEYN AS CHIEF FINANCIAL OFFICER CHRISTIAN DAL CIN RESIGNS AS CFO EFFECTIVE 31 MARCH 2025 Further company coverage: OSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncosil Medical
See all newsAustralia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone
Brief: Oncosil Medical Says FDA Grants Hde Approval For Oncosil Device For Distal Cholangiocarcinoma
Brief: Oncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25
Brief: Oncosil Medical Receives Saudi FDA Approval
Brief: Oncosil Medical Files For FDA Approval